Functional	O
block	O
for	O
1	O
alpha	O
,	O
25-dihydroxyvitamin	O
D3-mediated	O
gene	O
regulation	O
in	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

Elements	O
necessary	O
for	O
the	O
steroid	O
hormone	O
1	O
alpha	O
,	O
25-dihydroxyvitamin	O
D3	O
(	O
1	O
alpha	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
)	O
to	O
induce	O
a	O
biological	O
response	O
include	O
the	O
presence	O
of	O
specific	O
intracellular	B-protein
receptors	I-protein
(	O
vitamin	B-protein
D3	I-protein
receptors	I-protein
(	O
VDR	B-protein
)	O
)	O
and	O
modulation	O
of	O
gene	O
expression	O
via	O
hormone-activated	O
receptor	O
binding	O
to	O
regulatory	B-protein
regions	I-protein
of	O
target	B-DNA
genes	I-DNA
.	O

These	O
parameters	O
were	O
examined	O
in	O
normal	O
and	O
Epstein-Barr	B-cell_line
virus-immortalized	I-cell_line
human	I-cell_line
B	I-cell_line
cells	I-cell_line
and	O
compared	O
with	O
1	B-cell_line
alpha	I-cell_line
,	I-cell_line
25-	I-cell_line
(	I-cell_line
OH	I-cell_line
)	I-cell_line
2D3-responsive	I-cell_line
cells	I-cell_line
of	O
the	O
T	B-cell_type
and	I-cell_type
monocytic	I-cell_type
lineages	I-cell_type
.	O

Although	O
resting	O
tonsillar	O
B	O
cells	O
did	O
not	O
express	O
VDR	B-RNA
mRNA	I-RNA
,	O
activation	O
of	O
these	O
cells	O
with	O
interleukin-4	B-protein
induced	O
VDR	B-protein
in	O
the	O
absence	O
of	O
exogenously	O
supplemented	O
1	O
alpha	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
.	O

As	O
indicators	O
of	O
hormone-mediated	O
gene	O
regulation	O
we	O
analyzed	O
modulation	O
of	O
CD23	B-protein
,	O
a	O
common	B-protein
B	I-protein
cell/monocyte	I-protein
surface	I-protein
antigen	I-protein
,	O
and	O
24-hydroxylase	B-protein
.	O

1	O
alpha	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
inhibited	O
CD23	B-protein
expression	O
in	O
U937	B-cell_line
cells	I-cell_line
,	O
yet	O
failed	O
to	O
modulate	O
CD23	B-protein
expression	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

Furthermore	O
,	O
1	O
alpha	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
induced	O
24-hydroxylase	B-protein
mRNA	O
expression	O
and	O
metabolic	O
activity	O
in	O
both	O
U937	B-cell_line
cells	I-cell_line
and	O
lectin-activated	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
yet	O
failed	O
to	O
induce	O
24-hydroxylase	B-RNA
mRNA	I-RNA
or	O
its	O
metabolic	O
activity	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

These	O
findings	O
suggest	O
that	O
although	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
can	O
express	O
VDR	B-RNA
mRNA	I-RNA
and	O
protein	B-protein
,	O
they	O
exhibit	O
a	O
functional	O
block	O
for	O
vitamin	O
D-dependent	O
gene	O
regulation	O
.	O

THe	NULL
Journat	NULL
or	NULL
Brotocicat	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

18	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
6	NULL
,	NULL
pp	NULL
.	NULL

13437-13443	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Functional	NULL
Block	NULL
for	NULL
1	NULL
«	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
-mediated	NULL
Gene	NULL
Regulation	NULL
in	NULL
Human	NULL
B	NULL
Lymphocytes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
5	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
14	NULL
,	NULL
1994	NULL
)	NULL
John	NULL
W.	NULL
Morgan	NULL
,	NULL
G.	NULL
Satyanarayana	NULL
Reddyt	NULL
,	NULL
Milan	NULL
R.	NULL
Uskokovic§	NULL
,	NULL
Brian	NULL
K.	NULL
May1	NULL
,	NULL
John	NULL
L.	NULL
Omdabhl1	NULL
,	NULL
Abby	NULL
L.	NULL
Maizel	NULL
,	NULL
and	NULL
Surendra	NULL
Sharma	NULL
From	NULL
the	NULL
Section	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Roger	NULL
Williams	NULL
Cancer	NULL
/Medical	NULL
Center	NULL
,	NULL
Brown	NULL
University	NULL
,	NULL
Providence	NULL
,	NULL
Rhode	NULL
Island	NULL
02908	NULL
,	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Women	NULL
and	NULL
Infants	NULL
Hospital	NULL
,	NULL
Providence	NULL
,	NULL
Rhode	NULL
Island	NULL
02905	NULL
,	NULL
the	NULL
§Department	NULL
of	NULL
Chemistry	NULL
,	NULL
Hoffman-LaRoche	NULL
,	NULL
Inc.	NULL
,	NULL
Nutley	NULL
,	NULL
New	NULL
Jersey	NULL
07110	NULL
,	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
New	NULL
Mexico	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Albuquerque	NULL
,	NULL
New	NULL
Mexico	NULL
87102	NULL
Elements	NULL
necessary	NULL
for	NULL
the	NULL
steroid	NULL
hormone	NULL
1	NULL
«	NULL
,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
(	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
)	NULL
to	NULL
induce	NULL
a	NULL
biological	NULL
response	NULL
include	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
intracellular	NULL
receptors	NULL
(	NULL
vitamin	NULL
D	NULL
,	NULL
receptors	NULL
(	NULL
VDR	NULL
)	NULL
)	NULL
and	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
via	NULL
hormone-activated	NULL
receptor	NULL
binding	NULL
to	NULL
regulatory	NULL
regions	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

These	NULL
parameters	NULL
were	NULL
examined	NULL
in	NULL
normal	NULL
and	NULL
Epstein-Barr	NULL
virus-immortalized	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
compared	NULL
with	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-responsive	NULL
cells	NULL
of	NULL
the	NULL
T	NULL
and	NULL
monocytic	NULL
lineages	NULL
.	NULL

Although	NULL
resting	NULL
tonsillar	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
VDR	NULL
mRNA	NULL
,	NULL
activation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
interleu-kin-4	NULL
induced	NULL
VDR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenously	NULL
supplemented	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

As	NULL
indicators	NULL
of	NULL
hormone-mediated	NULL
gene	NULL
regulation	NULL
we	NULL
analyzed	NULL
modulation	NULL
of	NULL
CD23	NULL
,	NULL
a	NULL
common	NULL
B	NULL
cell/monocyte	NULL
surface	NULL
antigen	NULL
,	NULL
and	NULL
24-hydroxylase	NULL
.	NULL

1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
inhibited	NULL
CD23	NULL
expression	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
yet	NULL
failed	NULL
to	NULL
modulate	NULL
CD23	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
induced	NULL
24-hydroxylase	NULL
mRNA	NULL
expression	NULL
and	NULL
metabolic	NULL
activity	NULL
in	NULL
both	NULL
U937	NULL
cells	NULL
and	NULL
lectin-activated	NULL
T	NULL
cells	NULL
,	NULL
yet	NULL
failed	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
or	NULL
its	NULL
metabolic	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
although	NULL
human	NULL
B	NULL
lymphocytes	NULL
can	NULL
express	NULL
VDR	NULL
mRNA	NULL
and	NULL
protein	NULL
,	NULL
they	NULL
exhibit	NULL
a	NULL
functional	NULL
block	NULL
for	NULL
vitamin	NULL
D-dependent	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
steroid	NULL
hormone	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
'	NULL
the	NULL
active	NULL
metabolite	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
,	NULL
has	NULL
been	NULL
widely	NULL
documented	NULL
in	NULL
calcium	NULL
metabolism	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
observations	NULL
indicate	NULL
that	NULL
it	NULL
also	NULL
functions	NULL
as	NULL
an	NULL
important	NULL
immunohematopoietic	NULL
regulatory	NULL
hormone	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Newly	NULL
defined	NULL
biological	NULL
functions	NULL
ascribed	NULL
to	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
include	NULL
modulation	NULL
of	NULL
cellular	NULL
growth	NULL
,	NULL
differ-entiation	NULL
,	NULL
and	NULL
function	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
normal	NULL
and	NULL
malignant	NULL
hematopoietic	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
encompassing	NULL
both	NULL
lymphoid	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
and	NULL
myeloid	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
lineages	NULL
.	NULL

Although	NULL
nongenomic	NULL
effects	NULL
have	NULL
been	NULL
described	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
for	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
(	NULL
bone	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA54763	NULL
,	NULL
CA55910	NULL
,	NULL
CA45418	NULL
,	NULL
and	NULL
DK-39138	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Section	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Pathology	NULL
,	NULL
Roger	NULL
Williams	NULL
Medical	NULL
Center	NULL
,	NULL
Providence	NULL
,	NULL
RI	NULL
02908	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
401-456-6565	NULL
;	NULL
Fax	NULL
:	NULL
401-456-6569	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
;	NULL
1,24-	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
,	NULL
1,24-	NULL
(	NULL
R	NULL
)	NULL
,25-trihydroxyvitamin	NULL
D	NULL
,	NULL
;	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
HPLC	NULL
,	NULL
high	NULL
pressure	NULL
liquid	NULL
chromatography	NULL
;	NULL
IL-4	NULL
,	NULL
interleukin-4	NULL
;	NULL
PHA-P	NULL
,	NULL
phytohemagglutinin-purified	NULL
;	NULL
VDR	NULL
,	NULL
vitamin	NULL
D	NULL
,	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
;	NULL
VDRE	NULL
,	NULL
vitamin	NULL
D-responsive	NULL
element	NULL
.	NULL

intestinal	NULL
mucosa	NULL
)	NULL
,	NULL
a	NULL
majority	NULL
of	NULL
the	NULL
cellular	NULL
actions	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
specific	NULL
intracellular	NULL
vitamin	NULL
D	NULL
receptors	NULL
(	NULL
VDR	NULL
)	NULL
that	NULL
bind	NULL
the	NULL
hormone	NULL
with	NULL
high	NULL
affinity	NULL
and	NULL
selectivity	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Hormone-occupied	NULL
receptor	NULL
can	NULL
bind	NULL
to	NULL
genomic	NULL
responsive	NULL
elements	NULL
and	NULL
regulate	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
,	NULL
resulting	NULL
in	NULL
various	NULL
biologic	NULL
responses	NULL
.	NULL

Expression	NULL
of	NULL
VDR	NULL
has	NULL
been	NULL
documented	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Although	NULL
monocytic	NULL
cells	NULL
constitutively	NULL
express	NULL
VDR	NULL
which	NULL
can	NULL
be	NULL
up-regulated	NULL
by	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
their	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
requires	NULL
as	NULL
yet	NULL
poorly	NULL
defined	NULL
activation	NULL
event	NULL
(	NULL
s	NULL
)	NULL
(	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
acts	NULL
as	NULL
an	NULL
immunosuppressive	NULL
agent	NULL
on	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
fashion	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
other	NULL
immunosuppressive	NULL
drugs	NULL
,	NULL
such	NULL
as	NULL
cyclosporin	NULL
A	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
target	NULL
of	NULL
action	NULL
in	NULL
both	NULL
cases	NULL
is	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
modulating	NULL
early	NULL
gene	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
production	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
on	NULL
B	NULL
cell	NULL
function	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
fully	NULL
elucidated	NULL
,	NULL
and	NULL
initial	NULL
observations	NULL
have	NULL
yielded	NULL
conflicting	NULL
evidence	NULL
.	NULL

Initial	NULL
reports	NULL
indicated	NULL
that	NULL
VDR	NULL
expression	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
B	NULL
lymphocytes	NULL
upon	NULL
activation	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
,	NULL
yet	NULL
a	NULL
subsequent	NULL
report	NULL
cited	NULL
that	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
nonexpression	NULL
of	NULL
VDR	NULL
mRNA	NULL
is	NULL
a	NULL
dominant	NULL
feature	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
B	NULL
cell	NULL
proliferation	NULL
(	NULL
19	NULL
)	NULL
and	NULL
immunoglobulin	NULL
production	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
are	NULL
inhibited	NULL
by	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
others	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
detect	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
inhibition	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
may	NULL
be	NULL
further	NULL
compromised	NULL
by	NULL
the	NULL
involvement	NULL
of	NULL
accessory	NULL
cells	NULL
;	NULL
inhibition	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
may	NULL
be	NULL
an	NULL
indirect	NULL
result	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
inhibition	NULL
of	NULL
T	NULL
cell	NULL
help	NULL
and/or	NULL
proliferation	NULL
(	NULL
6	NULL
,	NULL
22	NULL
)	NULL
or	NULL
an	NULL
indirect	NULL
result	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
inhibition	NULL
of	NULL
cytokine	NULL
production	NULL
by	NULL
monocytes/macrophages	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
further	NULL
our	NULL
understanding	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
genomic	NULL
regulation	NULL
and	NULL
its	NULL
influence	NULL
on	NULL
B	NULL
cell	NULL
functions	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
its	NULL
effects	NULL
on	NULL
normal	NULL
human	NULL
tonsillar	NULL
B	NULL
cells	NULL
and	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-immortalized	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Hormone-mediated	NULL
regulation	NULL
of	NULL
B	NULL
cell	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
its	NULL
antiproliferation	NULL
effect	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
capacity	NULL
to	NULL
modulate	NULL
expression	NULL
of	NULL
a	NULL
differentiation	NULL
antigen	NULL
,	NULL
CD23	NULL
,	NULL
a	NULL
unique	NULL
type-II	NULL
transmembrane	NULL
protein	NULL
which	NULL
is	NULL
expressed	NULL
on	NULL
many	NULL
hematopoietic	NULL
cell	NULL
types	NULL
.	NULL

CD23	NULL
expression	NULL
is	NULL
induced	NULL
by	NULL
IL-4	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
23	NULL
)	NULL
and	NULL
monocytes	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
and	NULL
a	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
27	NULL
)	NULL
.	NULL

CD23	NULL
has	NULL
been	NULL
characterized	NULL
as	NULL
a	NULL
low-affinity	NULL
IgE	NULL
receptor	NULL
(	NULL
28	NULL
)	NULL
that	NULL
interacts	NULL
specifically	NULL
with	NULL
CD21	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
modulating	NULL
IgE-mediated	NULL
immune	NULL
response	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Human	NULL
B	NULL
cells	NULL
were	NULL
charac-terized	NULL
,	NULL
both	NULL
quantitatively	NULL
and	NULL
qualitatively	NULL
,	NULL
for	NULL
their	NULL
capacity	NULL
to	NULL
express	NULL
VDR	NULL
mRNA	NULL
and	NULL
protein	NULL
.	NULL

As	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
resting	NULL
lymphocytes	NULL
do	NULL
not	NULL
express	NULL
VDR	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
,	NULL
we	NULL
have	NULL
utilized	NULL
recombinant	NULL
human	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
EBV	NULL
immortalization	NULL
as	NULL
activating	NULL
agents	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
indicator	NULL
of	NULL
hor-	NULL
13437	NULL
13438	NULL
mone-mediated	NULL
gene	NULL
modulation	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
ability	NULL
to	NULL
convert	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
into	NULL
1a,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OBH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
human	NULL
B	NULL
lymphocytes	NULL
have	NULL
been	NULL
compared	NULL
and	NULL
contrasted	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
{	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
on	NULL
model	NULL
hematopoietic	NULL
cell	NULL
targets	NULL
;	NULL
U937	NULL
,	NULL
a	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
,	NULL
and	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
5	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
human	NULL
B	NULL
lymphocytes	NULL
exhibit	NULL
a	NULL
functional	NULL
block	NULL
for	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
-mediated	NULL
gene	NULL
regulation	NULL
,	NULL
irrespective	NULL
of	NULL
their	NULL
ability	NULL
to	NULL
express	NULL
VDR	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Lines-B9	NULL
is	NULL
an	NULL
EBV-positive	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
established	NULL
in	NULL
this	NULL
laboratory	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
was	NULL
routinely	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
fetal	NULL
calf	NULL
serum	NULL
)	NULL
and	NULL
2	NULL
mm	NULL
glutamine	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Tonsillar	NULL
B	NULL
and	NULL
T	NULL
Lymphocytes-Cells	NULL
from	NULL
normal	NULL
human	NULL
tonsils	NULL
were	NULL
prepared	NULL
by	NULL
mincing	NULL
the	NULL
tissue	NULL
and	NULL
extruding	NULL
through	NULL
a	NULL
fine	NULL
metal	NULL
mesh	NULL
screen	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
Ficoll-Hypaque	NULL
gradient	NULL
centrifugation	NULL
;	NULL
adherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
incubation	NULL
on	NULL
plastic	NULL
petri	NULL
dishes	NULL
.	NULL

B	NULL
and	NULL
T	NULL
lymphocyte	NULL
populations	NULL
were	NULL
fractionated	NULL
as	NULL
has	NULL
been	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Tonsillar	NULL
B	NULL
cells	NULL
prepared	NULL
in	NULL
this	NULL
manner	NULL
were	NULL
routinely	NULL
>	NULL
93	NULL
%	NULL
Bl-positive	NULL
,	NULL
<	NULL
1	NULL
%	NULL
Tll-positive	NULL
,	NULL
and	NULL
<	NULL
1	NULL
%	NULL
MY-9-	NULL
and	NULL
nonspecific	NULL
esterase-positive	NULL
.	NULL

Cell	NULL
Surface	NULL
Phenotyping-Cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

Pelleted	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
commercially	NULL
available	NULL
mouse	NULL
IgG	NULL
(	NULL
Coulter	NULL
Corp.	NULL
)	NULL
to	NULL
inhibit	NULL
nonspecific	NULL
binding	NULL
to	NULL
FeyR	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
washed	NULL
and	NULL
stained	NULL
with	NULL
fluorescein-conjugated	NULL
mouse	NULL
antibodies	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
washes	NULL
the	NULL
labeled	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
0.5	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
the	NULL
fluorescence	NULL
intensity	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
Coulter	NULL
EPICS	NULL
C	NULL
flow	NULL
cytometer	NULL
or	NULL
a	NULL
Becton	NULL
Dickinson	NULL
FACScan	NULL
.	NULL

Fluorescein	NULL
channels	NULL
were	NULL
amplified	NULL
logarithmically	NULL
with	NULL
a	NULL
range	NULL
of	NULL
four	NULL
decades	NULL
.	NULL

Histograms	NULL
represent	NULL
the	NULL
relative	NULL
number	NULL
of	NULL
cells	NULL
as	NULL
a	NULL
function	NULL
of	NULL
fluorescence	NULL
intensity	NULL
within	NULL
a	NULL
particular	NULL
gated	NULL
population	NULL
.	NULL

The	NULL
anti-CD23	NULL
monoclonal	NULL
antibody	NULL
mAb-25	NULL
was	NULL
obtained	NULL
from	NULL
AMAC	NULL
,	NULL
Inc.	NULL
(	NULL
West	NULL
Brook	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

The	NULL
anti-CD11b	NULL
(	NULL
Mo-1	NULL
)	NULL
monoclonal	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
Coulter	NULL
Immunology	NULL
(	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Lymphokines-Escherichia	NULL
coli-derived	NULL
recombinant	NULL
human	NULL
IL-4	NULL
(	NULL
IL-4	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
BioSource	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

10,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
;	NULL
-1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
synthesized	NULL
at	NULL
Hoffmann-LaRoche	NULL
.	NULL

The	NULL
hormone	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
ethanol	NULL
and	NULL
stored	NULL
at	NULL
-20	NULL
°C	NULL
.	NULL

None	NULL
of	NULL
the	NULL
cultures	NULL
contained	NULL
greater	NULL
than	NULL
0.01	NULL
%	NULL
ethanol	NULL
,	NULL
which	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
cellular	NULL
growth	NULL
,	NULL
phenotypic	NULL
profile	NULL
,	NULL
or	NULL
mRNA	NULL
expression	NULL
.	NULL

Molecular	NULL
Probes-The	NULL
molecular	NULL
probe	NULL
for	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
.	NULL

The	NULL
molecular	NULL
probe	NULL
for	NULL
human	NULL
24-hydroxylase	NULL
has	NULL
been	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

A	NULL
195-base	NULL
pair	NULL
PCR	NULL
product	NULL
complementary	NULL
to	NULL
sequences	NULL
of	NULL
a	NULL
constitutive	NULL
cellular	NULL
enzyme	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
reference	NULL
transcript	NULL
to	NULL
confirm	NULL
RNA	NULL
quality	NULL
and	NULL
quantity	NULL
(	NULL
38	NULL
)	NULL
.	NULL

60-Mer	NULL
synthetic	NULL
oligomers	NULL
complementary	NULL
to	NULL
sequences	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
CD23a-	NULL
and	NULL
CD23b-specific	NULL
exons	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
specific	NULL
for	NULL
each	NULL
CD23	NULL
molecular	NULL
isoform	NULL
.	NULL

The	NULL
synthetic	NULL
oligomer	NULL
5'-CTGAATATTGAC	NULL
CTTCCTCCATGGCGGTCCTGCTTGGATTCTCCGATGATGGAGCAC.-TC-3	NULL
'	NULL
,	NULL
which	NULL
is	NULL
complementary	NULL
to	NULL
the	NULL
CD23a	NULL
form	NULL
(	NULL
28	NULL
)	NULL
,	NULL
was	NULL
synthesized	NULL
by	NULL
Brown	NULL
University	NULL
.	NULL

The	NULL
synthetic	NULL
oligomer	NULL
5-CCTGGCTTGGAG-GATTCATTATGCTAAATTCTGCTTGTTCCAAGTTCCTGTTCTATTT-	NULL
which	NULL
is	NULL
complementary	NULL
to	NULL
the	NULL
CD23b	NULL
form	NULL
(	NULL
28	NULL
)	NULL
,	NULL
was	NULL
synthesized	NULL
by	NULL
Research	NULL
Genetics	NULL
(	NULL
Huntsville	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
gua-nidine	NULL
isothiocyanate/cesium	NULL
chloride	NULL
centrifugation	NULL
method	NULL
.	NULL

Polyadenylated	NULL
(	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
)	NULL
)	NULL
RNA	NULL
was	NULL
obtained	NULL
by	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-cellulose	NULL
chromatog-raphy	NULL
.	NULL

Aliquots	NULL
of	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
or	NULL
5-10	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
were	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
filters	NULL
(	NULL
Zeta	NULL
;	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Recombinant	NULL
DNA	NULL
inserts	NULL
complementary	NULL
to	NULL
VDR	NULL
mRNA	NULL
were	NULL
purified	NULL
by	NULL
isolating	NULL
a	NULL
2.1-kilobase	NULL
EcoRI	NULL
fragment	NULL
from	NULL
the	NULL
pGEM3	NULL
plasmid	NULL
.	NULL

Recombinant	NULL
DNA	NULL
inserts	NULL
complementary	NULL
to	NULL
human	NULL
24-hydroxylase	NULL
mRNA	NULL
were	NULL
purified	NULL
by	NULL
isolating	NULL
a	NULL
1.8-kilobase	NULL
EcoRI	NULL
fragment	NULL
from	NULL
the	NULL
pBKS*	NULL
plasmid	NULL
.	NULL

cDNA	NULL
and	NULL
oligonucleotide	NULL
molecular	NULL
probes	NULL
were	NULL
``	NULL
P-labeled	NULL
by	NULL
random	NULL
primer	NULL
synthesis	NULL
or	NULL
5'-end	NULL
labeling	NULL
,	NULL
respectively	NULL
.	NULL

Prehybridization	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1	NULL
@	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
Cellular	NULL
Extract	NULL
Preparation-Cellular	NULL
extracts	NULL
were	NULL
made	NULL
with	NULL
modifications	NULL
of	NULL
the	NULL
methods	NULL
of	NULL
Marzluff	NULL
(	NULL
40	NULL
)	NULL
and	NULL
Shapiro	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
then	NULL
suspended	NULL
in	NULL
5	NULL
x	NULL
packed	NULL
cell	NULL
volumes	NULL
of	NULL
1	NULL
x	NULL
hypo-TD	NULL
+	NULL
protease	NULL
inhibitors	NULL
(	NULL
100	NULL
mx	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
2	NULL
mm	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
2	NULL
ug/ml	NULL
aproti-nin	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
brief	NULL
incubation	NULL
period	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
at	NULL
400	NULL
x	NULL
g.	NULL
The	NULL
cell	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
2	NULL
x	NULL
packed	NULL
cell	NULL
volumes	NULL
of	NULL
1	NULL
x	NULL
hypo-TD	NULL
+	NULL
protease	NULL
inhibitors	NULL
and	NULL
disrupted	NULL
by	NULL
Dounce	NULL
homogenization	NULL
with	NULL
a	NULL
tight-fitting	NULL
pestle	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
then	NULL
made	NULL
to	NULL
0.3	NULL
M	NULL
KC	NULL
]	NULL
and	NULL
allowed	NULL
to	NULL
incubate	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Subsequently	NULL
the	NULL
lysate	NULL
was	NULL
centrifuged	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
in	NULL
an	NULL
L8-55	NULL
Beckman	NULL
ultracen-trifuge	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
then	NULL
made	NULL
20	NULL
%	NULL
with	NULL
glycerol	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Total	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Protein	NULL
Assay	NULL
kit	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
VDR-The	NULL
anti-vitamin	NULL
D	NULL
receptor	NULL
monoclonal	NULL
antibody	NULL
9477	NULL
(	NULL
Affinity	NULL
Bioreagents	NULL
)	NULL
was	NULL
covalently	NULL
cross-linked	NULL
to	NULL
protein-G-Sepharose	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Schneider	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
.	NULL

One-milligram	NULL
aliquots	NULL
of	NULL
total	NULL
cellular	NULL
protein	NULL
were	NULL
preabsorbed	NULL
with	NULL
activated	NULL
quenched	NULL
protein-G-Sepharose	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Subsequently	NULL
,	NULL
absorbed	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
derivitized	NULL
beads	NULL
(	NULL
~15	NULL
pl	NULL
)	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
gentle	NULL
mix-ing	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
the	NULL
derivitized	NULL
beads	NULL
were	NULL
washed	NULL
with	NULL
TEDK/0.3*	NULL
buffer	NULL
(	NULL
10	NULL
my	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1.5	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
0.3	NULL
1	NULL
KCl	NULL
,	NULL
2	NULL
mm	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
2	NULL
ug/ml	NULL
apro-tinin	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
)	NULL
and	NULL
finally	NULL
with	NULL
0.5	NULL
m	NULL
Tris	NULL
,	NULL
pH	NULL
6.8	NULL
.	NULL

Western	NULL
Blotting-Immunoprecipitated	NULL
samples	NULL
were	NULL
heated	NULL
to	NULL
100	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
in	NULL
SDS-denaturing	NULL
buffer	NULL
and	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
as	NULL
described	NULL
by	NULL
Laemmli	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
elec-trophoretically	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Hybond	NULL
;	NULL
Am-ersham	NULL
Corp.	NULL
)	NULL
in	NULL
a	NULL
Trans-Blot	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
)	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instruction	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
with	NULL
TBS-T	NULL
buffer	NULL
,	NULL
pH	NULL
7.6	NULL
(	NULL
20	NULL
my	NULL
Tris	NULL
base	NULL
;	NULL
137	NULL
mm	NULL
NaCl	NULL
;	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
,	NULL
1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
1	NULL
mg/ml	NULL
chicken	NULL
egg	NULL
albumin	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
solution	NULL
containing	NULL
2	NULL
ug/ml	NULL
9A77	NULL
antibody	NULL
,	NULL
1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
1	NULL
mg/ml	NULL
chicken	NULL
egg	NULL
albumin	NULL
in	NULL
TBS-T	NULL
and	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
22	NULL
°C	NULL
with	NULL
gentle	NULL
rocking	NULL
.	NULL

Postincubsation	NULL
,	NULL
membranes	NULL
were	NULL
washed	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
solution	NULL
containing	NULL
a	NULL
1:5,000	NULL
dilution	NULL
of	NULL
peroxidase-linked	NULL
sheep	NULL
anti-rat	NULL
immunoglobulin	NULL
,	NULL
1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
1	NULL
mg/ml	NULL
chicken	NULL
egg	NULL
albumin	NULL
in	NULL
TBS-T	NULL
and	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
22	NULL
°C	NULL
with	NULL
gentle	NULL
rocking	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
antibody	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
reagents	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Metabolism	NULL
Studies-1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
metabolism	NULL
studies	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
24-hydroxylase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
monitoring	NULL
the	NULL
conversion	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
into	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
in	NULL
intact	NULL
cells	NULL
using	NULL
substrate	NULL
concentrations	NULL
of	NULL
1a,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
(	NULL
1	NULL
um	NULL
)	NULL
above	NULL
the	NULL
K	NULL
,	NULL
,	NULL
values	NULL
reported	NULL
for	NULL
this	NULL
enzyme	NULL
(	NULL
45	NULL
)	NULL
.	NULL

High	NULL
substrate	NULL
concentrations	NULL
enabled	NULL
monitoring	NULL
of	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
production	NULL
by	NULL
utilization	NULL
of	NULL
HPLC	NULL
combined	NULL
with	NULL
a	NULL
photodiode	NULL
array	NULL
detector	NULL
.	NULL

The	NULL
primary	NULL
metabolite	NULL
(	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
)	NULL
and	NULL
other	NULL
minor	NULL
metabolites	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
produced	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
were	NULL
identified	NULL
by	NULL
their	NULL
UV	NULL
spectra	NULL
obtained	NULL
during	NULL
the	NULL
HPLC	NULL
analysis	NULL
of	NULL
the	NULL
lipid	NULL
extract	NULL
using	NULL
the	NULL
photodiode	NULL
array	NULL
detector	NULL
.	NULL

Approximately	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
200	NULL
units/ml	NULL
IL-4	NULL
to	NULL
effect	NULL
cellular	NULL
activation	NULL
;	NULL
tonsillar	NULL
T	NULL
cells	NULL
were	NULL
also	NULL
activated	NULL
with	NULL
15	NULL
ug/ml	NULL
PHA-P.	NULL
14,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
subsequently	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
5	NULL
x	NULL
10~	NULL
m	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
h	NULL
to	NULL
maximally	NULL
stimulate	NULL
metabolic	NULL
enzymes	NULL
.	NULL

At	NULL
72	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
media	NULL
and	NULL
FCS	NULL
were	NULL
replenished	NULL
,	NULL
and	NULL
1	NULL
ux	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
;	NULL
D	NULL
,	NULL
was	NULL
added	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h.	NULL
The	NULL
reaction	NULL
was	NULL
then	NULL
stopped	NULL
with	NULL
methanol	NULL
,	NULL
and	NULL
lipid	NULL
extraction	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Bligh	NULL
and	NULL
Dyer	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
lipid	NULL
extract	NULL
was	NULL
analyzed	NULL
by	NULL
HPLC	NULL
using	NULL
a	NULL
Waters	NULL
model	NULL
600	NULL
equipped	NULL
with	NULL
a	NULL
model	NULL
990	NULL
photodiode	NULL
array	NULL
detector	NULL
(	NULL
Waters	NULL
Associates	NULL
,	NULL
Milford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Mass	NULL
spectra	NULL
(	NULL
70	NULL
eV	NULL
)	NULL
of	NULL
purified	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
produced	NULL
in	NULL
both	NULL
U937	NULL
cells	NULL
and	NULL
normal	NULL
tonsillar	NULL
T	NULL
cells	NULL
were	NULL
obtained	NULL
on	NULL
a	NULL
Hewlett-Packard	NULL
5985	NULL
B	NULL
mass	NULL
spectrometer	NULL
as	NULL
described	NULL
(	NULL
44	NULL
,	NULL
47	NULL
)	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
10,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
on	NULL
CD23	NULL
Expression-Our	NULL
preliminary	NULL
experiments	NULL
suggested	NULL
that	NULL
14,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
did	NULL
not	NULL
modulate	NULL
proliferation	NULL
of	NULL
either	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
or	NULL
activated	NULL
normal	NULL
human	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
conflict	NULL
with	NULL
the	NULL
reported	NULL
activity	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
on	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
15	NULL
,	NULL
33	NULL
)	NULL
and	NULL
monocytes	NULL
(	NULL
32	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1	NULL
«	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
Panel	NULL
A	NULL
Panel	NULL
B	NULL
Relative	NULL
cell	NULL
number	NULL
Fluorescence	NULL
intensity	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
CD23	NULL
expression	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
monoblasts	NULL
)	NULL
and	NULL
B9	NULL
cells	NULL
(	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
)	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10~®	NULL
m	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
plus	NULL
100	NULL
units/ml	NULL
IL-4	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
either	NULL
anti-CD23	NULL
mAb-25	NULL
monoclonal	NULL
antibody	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
anti-Mo1	NULL
monoclonal	NULL
antibody	NULL
(	NULL
panel	NULL
!	NULL

B	NULL
)	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

B9	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
anti-CD23	NULL
mAb-25	NULL
monoclonal	NULL
antibody	NULL
(	NULL
panel	NULL
!	NULL

C	NULL
)	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Clear	NULL
histograms	NULL
depict	NULL
unstimulated	NULL
cells	NULL
;	NULL
shaded	NULL
histograms	NULL
depict	NULL
cells	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
plus	NULL
100	NULL
units/ml	NULL
IL-4	NULL
.	NULL

The	NULL
x	NULL
axis	NULL
shows	NULL
the	NULL
logarithmic	NULL
intensity	NULL
of	NULL
green	NULL
fluorescence	NULL
and	NULL
the	NULL
y	NULL
axis	NULL
depicts	NULL
relative	NULL
cell	NULL
number	NULL
.	NULL

observations	NULL
we	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
treatment	NULL
on	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD23	NULL
antigen	NULL
.	NULL

As	NULL
CD23	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
inhibited	NULL
by	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
in	NULL
monocytes	NULL
(	NULL
50	NULL
)	NULL
,	NULL
it	NULL
is	NULL
an	NULL
excellent	NULL
model	NULL
for	NULL
comparative	NULL
analysis	NULL
of	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
gene	NULL
regulation	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
monocytic	NULL
cells	NULL
.	NULL

As	NULL
depicted	NULL
by	NULL
the	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
histograms	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
IL-4-mediated	NULL
enhancement	NULL
of	NULL
CD23	NULL
expression	NULL
in	NULL
monocytic	NULL
U937	NULL
cells	NULL
was	NULL
negatively	NULL
modulated	NULL
by	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Concurrently	NULL
these	NULL
cells	NULL
were	NULL
also	NULL
analyzed	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
CD11b	NULL
(	NULL
Mo-1	NULL
)	NULL
,	NULL
an	NULL
adhesion	NULL
molecule	NULL
of	NULL
the	NULL
B	NULL
,	NULL
-integrin	NULL
family	NULL
(	NULL
51	NULL
)	NULL
whose	NULL
expression	NULL
correlates	NULL
well	NULL
with	NULL
monocytic	NULL
differentiation	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
IL-4	NULL
dramatically	NULL
up-regulated	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD11b	NULL
antigen	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
B	NULL
)	NULL
,	NULL
indicative	NULL
of	NULL
cellular	NULL
differentiation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
B9	NULL
cells	NULL
with	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
did	NULL
not	NULL
modulate	NULL
IL-4-enhanced	NULL
CD23	NULL
surface	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
CD23	NULL
protein	NULL
expression	NULL
was	NULL
not	NULL
modulated	NULL
in	NULL
these	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
other	NULL
intervals	NULL
of	NULL
culture	NULL
.	NULL

Analogously	NULL
,	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
did	NULL
not	NULL
modulate	NULL
IL-4-induced	NULL
CD23	NULL
protein	NULL
expression	NULL
in	NULL
normal	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
down-regu-lates	NULL
CD23	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
yet	NULL
does	NULL
not	NULL
modulate	NULL
CD23	NULL
antigen	NULL
expression	NULL
in	NULL
either	NULL
normal	NULL
or	NULL
immortalized	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
interpretation	NULL
of	NULL
these	NULL
results	NULL
is	NULL
hindered	NULL
by	NULL
the	NULL
13439	NULL
EBV+*	NULL
B	NULL
cells	NULL
U937	NULL
cells	NULL
|	NULL
I	NULL
|	NULL
C	NULL
oo	NULL
o	NULL
o	NULL
r	NULL
r	NULL
rrr	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
2D3	NULL
#	NULL
0	NULL
®	NULL
=	NULL
+	NULL
+	NULL
+	NULL
L	NULL
T	NULL
Tt	NULL
Tt	NULL
T	NULL
1	NULL
1	NULL
H3	NULL
CD23b	NULL
--	NULL
_	NULL
*	NULL
»	NULL
WB	NULL
to	NULL
bo	NULL
iod	NULL
io	NULL
__	NULL
tWigo	NULL
(	NULL
1.6	NULL
kb	NULL
)	NULL
o	NULL
$	NULL
0	NULL
#	NULL
0	NULL
-	NULL
-	NULL
caro	NULL
--	NULL
@	NULL
9	NULL
@	NULL
p	NULL
EDU	NULL
as	NULL
=+	NULL
th	NULL
twp	NULL
tt	NULL
tad	NULL
tap	NULL
(	NULL
1.3	NULL
kb	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
on	NULL
CD23b	NULL
mRNA	NULL
expression	NULL
.	NULL

U937	NULL
cells	NULL
and	NULL
B9	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
various	NULL
concentrations	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
plus	NULL
100	NULL
units/ml	NULL
IL4	NULL
.	NULL

After	NULL
72	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
electrophoresed	NULL
and	NULL
then	NULL
blotted	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
60-mer	NULL
CD23b	NULL
antisense	NULL
oligonucleotide	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
195-base	NULL
pair	NULL
PCR	NULL
product	NULL
complementary	NULL
to	NULL
sequences	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
to	NULL
confirm	NULL
RNA	NULL
quality	NULL
and	NULL
quantity	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Lanes	NULL
1-6	NULL
,	NULL
B9	NULL
cells	NULL
:	NULL
unstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
EtOH	NULL
vehicle	NULL
as	NULL
control	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
10	NULL
%	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
107	NULL
m	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
10	NULL
m	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Lanes	NULL
7-12	NULL
,	NULL
U937	NULL
cells	NULL
:	NULL
unstimulated	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
EtOH	NULL
vehicle	NULL
as	NULL
control	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
10°	NULL
m	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
107	NULL
m	NULL
10,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
IL-4	NULL
+	NULL
10	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

observation	NULL
that	NULL
CD23	NULL
can	NULL
be	NULL
expressed	NULL
in	NULL
at	NULL
least	NULL
two	NULL
molecular	NULL
isoforms	NULL
,	NULL
designated	NULL
CD23a	NULL
and	NULL
CD23b	NULL
,	NULL
which	NULL
are	NULL
the	NULL
result	NULL
of	NULL
different	NULL
initiation	NULL
sites	NULL
and	NULL
alternative	NULL
splicing	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Both	NULL
isoforms	NULL
are	NULL
expressed	NULL
on	NULL
IL-4-treated	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
only	NULL
the	NULL
b	NULL
isoform	NULL
is	NULL
expressed	NULL
on	NULL
monocytes	NULL
.	NULL

Thus	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
may	NULL
preferentially	NULL
modulate	NULL
expression	NULL
of	NULL
only	NULL
a	NULL
single	NULL
molecular	NULL
isoform	NULL
or	NULL
induce	NULL
reciprocal	NULL
modulation	NULL
of	NULL
the	NULL
two	NULL
isoforms	NULL
,	NULL
thereby	NULL
rendering	NULL
analysis	NULL
by	NULL
antigen	NULL
expression	NULL
inappropriate	NULL
.	NULL

To	NULL
circumvent	NULL
this	NULL
dilemma	NULL
,	NULL
we	NULL
exploited	NULL
sequence	NULL
differences	NULL
in	NULL
the	NULL
5'-end	NULL
region	NULL
of	NULL
CD23a	NULL
and	NULL
CD23b	NULL
cDNAs	NULL
by	NULL
utilizing	NULL
unique	NULL
antisense	NULL
oligonucleotide	NULL
probes	NULL
complementary	NULL
to	NULL
these	NULL
regions	NULL
.	NULL

Using	NULL
these	NULL
antisense	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
we	NULL
analyzed	NULL
CD23a	NULL
and	NULL
CD23b	NULL
mRNA	NULL
expression	NULL
in	NULL
U937	NULL
and	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
treated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
CD23b	NULL
mRNA	NULL
expression	NULL
was	NULL
found	NULL
to	NULL
be	NULL
significantly	NULL
down-modulated	NULL
in	NULL
U937	NULL
cells	NULL
after	NULL
culture	NULL
with	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD23b	NULL
mRNA	NULL
was	NULL
not	NULL
modulated	NULL
in	NULL
B9	NULL
cells	NULL
treated	NULL
with	NULL
as	NULL
much	NULL
as	NULL
1	NULL
um	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
treatment	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
did	NULL
not	NULL
modulate	NULL
CD23a	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
flow	NULL
cytometry	NULL
analysis	NULL
,	NULL
substantiating	NULL
the	NULL
contention	NULL
that	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
negatively	NULL
modulates	NULL
CD23	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
yet	NULL
does	NULL
not	NULL
modulate	NULL
CD23	NULL
expression	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Induction	NULL
of	NULL
VDR	NULL
mRNA	NULL
in	NULL
B	NULL
Lymphocytes-The	NULL
apparent	NULL
refractory	NULL
response	NULL
of	NULL
B	NULL
lymphocytes	NULL
to	NULL
inhibition	NULL
of	NULL
proliferation	NULL
or	NULL
alteration	NULL
of	NULL
phenotype	NULL
expression	NULL
by	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
led	NULL
us	NULL
to	NULL
question	NULL
whether	NULL
these	NULL
cells	NULL
express	NULL
or	NULL
could	NULL
be	NULL
induced	NULL
to	NULL
express	NULL
VDR	NULL
.	NULL

We	NULL
undertook	NULL
experiments	NULL
to	NULL
determine	NULL
if	NULL
VDR	NULL
mRNA	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
either	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
,	NULL
or	NULL
normal	NULL
human	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IL-4	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
indicator	NULL
of	NULL
the	NULL
4.6-kilobase	NULL
VDR	NULL
mRNA	NULL
(	NULL
18	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
VDR	NULL
mRNA	NULL
signal	NULL
was	NULL
weak	NULL
from	NULL
total	NULL
RNA	NULL
obtained	NULL
from	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
it	NULL
was	NULL
clearly	NULL
13440	NULL
A	NULL
B	NULL
rIL-4	NULL
-	NULL
-	NULL
&	NULL
-	NULL
%	NULL
%	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
2Da	NULL
®	NULL
VDR	NULL
-=-	NULL
-	NULL
wh	NULL
with	NULL
(	NULL
4.6	NULL
kb	NULL
)	NULL
f	NULL
GAPDH	NULL
--	NULL
a*	NULL
(	NULL
1.3	NULL
kb	NULL
)	NULL
ﬂ	NULL
@	NULL
linking	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
VDR	NULL
mRNA	NULL
.	NULL

B9	NULL
cells	NULL
,	NULL
normal	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
%	NULL
m	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
24	NULL
h.	NULL
Tonsillar	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
units/ml	NULL
IL-4	NULL
for	NULL
72	NULL
h.	NULL
10	NULL
ug	NULL
of	NULL
polyadenylated	NULL
mRNA	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
4	NULL
)	NULL
or	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
were	NULL
electrophoresed	NULL
and	NULL
then	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
hVDR	NULL
cDNA	NULL
probe	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
195-base	NULL
pair	NULL
PCR	NULL
product	NULL
complementary	NULL
to	NULL
sequences	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
to	NULL
confirm	NULL
RNA	NULL
quality	NULL
(	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
B9	NULL
cells	NULL
(	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
)	NULL
unstimulated	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
B9	NULL
cells	NULL
(	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
)	NULL
+	NULL
10°	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
B9	NULL
cells	NULL
(	NULL
total	NULL
RNA	NULL
)	NULL
+	NULL
10	NULL
%	NULL
m	NULL
14,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
U937	NULL
cells	NULL
(	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
)	NULL
+	NULL
10	NULL
%	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
total	NULL
RNA	NULL
)	NULL
unstimulated	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
total	NULL
RNA	NULL
)	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
.	NULL

evident	NULL
with	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Unstimulated	NULL
tonsillar	NULL
B	NULL
cells	NULL
exhibited	NULL
no	NULL
detectable	NULL
mRNA	NULL
hybridizing	NULL
with	NULL
the	NULL
hVDR	NULL
probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
yet	NULL
activation	NULL
with	NULL
IL-4	NULL
was	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
VDR	NULL
mRNA	NULL
expression	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
this	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
interleukin-4-mediated	NULL
induction	NULL
of	NULL
VDR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
.	NULL

Although	NULL
trace	NULL
quantities	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
may	NULL
have	NULL
been	NULL
present	NULL
in	NULL
the	NULL
FCS	NULL
,	NULL
it	NULL
was	NULL
clearly	NULL
insufficient	NULL
to	NULL
up-regulate	NULL
VDR	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-4-mediated	NULL
activation	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
support	NULL
the	NULL
contention	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
that	NULL
vitamin	NULL
D	NULL
receptor	NULL
expression	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
activated	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Demonstration	NULL
of	NULL
VDR	NULL
Protein	NULL
by	NULL
-	NULL
Immunoblot-Demonstration	NULL
of	NULL
expression	NULL
of	NULL
VDR	NULL
mRNA	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
translation	NULL
of	NULL
VDR	NULL
mRNA	NULL
was	NULL
occurring	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
and	NULL
if	NULL
this	NULL
event	NULL
resulted	NULL
in	NULL
a	NULL
mature	NULL
protein	NULL
of	NULL
correct	NULL
molecular	NULL
mass	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Immunoblotting	NULL
analysis	NULL
of	NULL
immunoprecipitated	NULL
extracts	NULL
from	NULL
cells	NULL
of	NULL
various	NULL
hematopoietic	NULL
lineages	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
the	NULL
chick	NULL
intestinal	NULL
VDR	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Immunoprecipitated	NULL
extracts	NULL
obtained	NULL
from	NULL
lectin-activated	NULL
tonsillar	NULL
T	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
reference	NULL
sources	NULL
known	NULL
to	NULL
express	NULL
VDR	NULL
protein	NULL
(	NULL
12	NULL
,	NULL
31	NULL
,	NULL
33	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
cross-reacting	NULL
protein	NULL
with	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
approximately	NULL
50	NULL
kDa	NULL
was	NULL
detected	NULL
in	NULL
immunoprecipitated	NULL
extracts	NULL
from	NULL
activated	NULL
tonsillar	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Cross-reactive	NULL
protein	NULL
was	NULL
also	NULL
detected	NULL
,	NULL
albeit	NULL
to	NULL
a	NULL
lesser	NULL
ex-tent	NULL
,	NULL
in	NULL
immunoprecipitated	NULL
extracts	NULL
from	NULL
activated	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
as	NULL
well	NULL
as	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
cross-reactive	NULL
protein	NULL
derived	NULL
from	NULL
activated	NULL
tonsillar	NULL
B	NULL
cells	NULL
was	NULL
detected	NULL
as	NULL
two	NULL
distinct	NULL
molecular	NULL
species	NULL
;	NULL
the	NULL
cross-reactive	NULL
protein	NULL
exhibiting	NULL
a	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
may	NULL
be	NULL
indicative	NULL
of	NULL
occupied	NULL
VDR	NULL
which	NULL
have	NULL
undergone	NULL
covalent	NULL
modification	NULL
(	NULL
57	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
species	NULL
exhibiting	NULL
a	NULL
Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1	NULL
@	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
;	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
ko	NULL
T	NULL
OJ	NULL
1	NULL
1	NULL
T	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
VDR	NULL
protein	NULL
expression	NULL
.	NULL

Chemi-luminescent	NULL
Western	NULL
blot	NULL
of	NULL
VDR	NULL
protein	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
cytosol	NULL
protein	NULL
were	NULL
immunoprecipitated	NULL
overnight	NULL
with	NULL
anti-VDR	NULL
9A77	NULL
antibody	NULL
chemically	NULL
cross-linked	NULL
to	NULL
protein-G-Sepharose	NULL
and	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
immunoprecipitated	NULL
extract	NULL
from	NULL
tonsillar	NULL
T	NULL
cells	NULL
activated	NULL
with	NULL
10	NULL
ug/ml	NULL
PHA	NULL
and	NULL
100	NULL
units/ml	NULL
IL-4	NULL
for	NULL
72	NULL
h	NULL
)	NULL
and	NULL
lane	NULL
6	NULL
(	NULL
immunoprecipitated	NULL
extract	NULL
from	NULL
U937	NULL
cells	NULL
activated	NULL
with	NULL
100	NULL
units/ml	NULL
IL4	NULL
and	NULL
10~®	NULL
m	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
96	NULL
h	NULL
)	NULL
served	NULL
as	NULL
positive	NULL
controls	NULL
for	NULL
VDR	NULL
protein	NULL
expression	NULL
.	NULL

Lane	NULL
2	NULL
contained	NULL
an	NULL
immunoprecipitated	NULL
extract	NULL
from	NULL
tonsillar	NULL
B	NULL
cells	NULL
activated	NULL
with	NULL
100	NULL
units/ml	NULL
IL-4	NULL
and	NULL
10	NULL
%	NULL
m	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
72	NULL
h.	NULL
Lanes	NULL
4	NULL
and	NULL
5	NULL
contained	NULL
immunoprecipitated	NULL
extracts	NULL
from	NULL
an	NULL
EBV-immortalized	NULL
cell	NULL
line	NULL
(	NULL
B9	NULL
)	NULL
activated	NULL
for	NULL
96	NULL
h	NULL
with	NULL
either	NULL
10	NULL
%	NULL
m	NULL
1a,25-	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
10	NULL
%	NULL
m	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
plus	NULL
100	NULL
units/ml	NULL
IL-4	NULL
,	NULL
respectively	NULL
.	NULL

Lane	NULL
3	NULL
depicts	NULL
an	NULL
immunoprecipitated	NULL
extract	NULL
from	NULL
non-activated	NULL
total	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
migration	NULL
positions	NULL
of	NULL
human	NULL
VDR	NULL
at	NULL
52	NULL
kDa	NULL
.	NULL

reduced	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
the	NULL
only	NULL
immunoreactive	NULL
protein	NULL
detected	NULL
in	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

VDR	NULL
protein	NULL
detected	NULL
in	NULL
the	NULL
cellular	NULL
extract	NULL
obtained	NULL
from	NULL
nonacti-vated	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
probably	NULL
contributed	NULL
by	NULL
contaminating	NULL
monocytes	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
constitutively	NULL
express	NULL
VDR	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
highlights	NULL
the	NULL
exquisite	NULL
sensitivity	NULL
of	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
technique	NULL
.	NULL

The	NULL
additional	NULL
cross-reacting	NULL
protein	NULL
detected	NULL
in	NULL
immunoprecipitated	NULL
cellular	NULL
extracts	NULL
from	NULL
activated	NULL
tonsillar	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
is	NULL
probably	NULL
nonspecific	NULL
,	NULL
as	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
other	NULL
immunoprecipitated	NULL
cellular	NULL
extracts	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
translation	NULL
of	NULL
VDR	NULL
mRNA	NULL
does	NULL
occur	NULL
in	NULL
activated	NULL
human	NULL
tonsillar	NULL
B	NULL
cells	NULL
and	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
resulting	NULL
protein	NULL
exhibits	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
VDR	NULL
protein	NULL
derived	NULL
from	NULL
activated	NULL
T	NULL
lymphocytes	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

B	NULL
Lymphocytes	NULL
Fail	NULL
to	NULL
Metabolize	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-As	NULL
activated	NULL
normal	NULL
and	NULL
immortalized	NULL
B	NULL
lymphocytes	NULL
were	NULL
found	NULL
to	NULL
express	NULL
VDR	NULL
mRNA	NULL
and	NULL
protein	NULL
,	NULL
yet	NULL
were	NULL
apparently	NULL
refractory	NULL
to	NULL
antiproliferative	NULL
or	NULL
differentiation	NULL
effects	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
,	NULL
we	NULL
exploited	NULL
the	NULL
phenomenon	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-de-pendent	NULL
24-hydroxylase	NULL
induction	NULL
to	NULL
determine	NULL
whether	NULL
a	NULL
functional	NULL
hormone-receptor	NULL
complex	NULL
was	NULL
established	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
that	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
mediates	NULL
its	NULL
control	NULL
of	NULL
24-hydroxylase	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
58	NULL
)	NULL
;	NULL
or-dinarily	NULL
,	NULL
24-hydroxylase	NULL
activity	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
hematopoietic	NULL
cells	NULL
unless	NULL
they	NULL
are	NULL
stimulated	NULL
with	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
59	NULL
)	NULL
.	NULL

From	NULL
the	NULL
representative	NULL
HPLC	NULL
chromatographic	NULL
profiles	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
U937	NULL
cells	NULL
pretreated	NULL
with	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
;	NULL
D	NULL
,	NULL
(	NULL
5	NULL
x	NULL
10~®	NULL
m	NULL
)	NULL
attain	NULL
the	NULL
ability	NULL
to	NULL
convert	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
into	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
that	NULL
this	NULL
ability	NULL
is	NULL
enhanced	NULL
significantly	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
B9	NULL
and	NULL
normal	NULL
tonsillar	NULL
B	NULL
cells	NULL
pretreated	NULL
with	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
,	NULL
did	NULL
not	NULL
show	NULL
any	NULL
evidence	NULL
of	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
production	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
tonsillar	NULL
T	NULL
cells	NULL
(	NULL
activated	NULL
with	NULL
PHA	NULL
and	NULL
IL-4	NULL
)	NULL
produced	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
the	NULL
production	NULL
rate	NULL
of	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
plus	NULL
IL-4	NULL
.	NULL

B	NULL
Lymphocytes	NULL
Fail	NULL
to	NULL
Induce	NULL
24-Hydroxylase	NULL
mRNA-Since	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
metabolism	NULL
is	NULL
directly	NULL
linked	NULL
to	NULL
hormone-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
panel	NULL
A	NULL
,	NULL
a	NULL
human	NULL
24-hydroxylase	NULL
cDNA	NULL
probe	NULL
hybridized	NULL
to	NULL
a	NULL
single	NULL
3.4-kilobase	NULL
mRNA	NULL
species	NULL
derived	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
;	NULL
Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1	NULL
@	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
;	NULL
13441	NULL
U937	NULL
U937	NULL
+	NULL
rIL4	NULL
B9	NULL
+	NULL
rIL4	NULL
Tonsil	NULL
B	NULL
+	NULL
rIL4	NULL
Tonsil	NULL
T	NULL
+	NULL
rIL4	NULL
+	NULL
PHA	NULL
3	NULL
L	NULL
Docu	NULL
Loga	NULL
Gaga	NULL
3	NULL
ochoa	NULL
Liaaa	NULL
Lags	NULL
ugg	NULL
dugaal	NULL
3	NULL
ious	NULL
|	NULL
uud	NULL
ca	NULL
A	NULL
?	NULL

ii	NULL
Loca	NULL
uca	NULL
Goaa	NULL
8	NULL
cocoa	NULL
a	NULL
Loga	NULL
Gaga	NULL
gaga	NULL
adul	NULL
1	NULL
I	NULL
3	NULL
3	NULL
[	NULL
3	NULL
L	NULL
E	NULL
8	NULL
§	NULL
3	NULL
L	NULL
gl	NULL
.	NULL

$	NULL
|	NULL
s	NULL
:	NULL
&	NULL
}	NULL
Fo	NULL
}	NULL
Ly	NULL
F	NULL
3	NULL
3	NULL
§	NULL
8	NULL
-	NULL
#	NULL
)	NULL
CC	NULL
G	NULL
v	NULL
l	NULL
a	NULL
{	NULL
fie	NULL
<	NULL
a	NULL
]	NULL
tSj	NULL
el	NULL
f	NULL
£	NULL
ef	NULL
)	NULL
_J	NULL
roper	NULL
mterprmnprmmpremmpmmprert	NULL
memimrfmmepmmprmr	NULL
irt	NULL
vvvvﬂvrf'|'*	NULL
``	NULL
1	NULL
``	NULL
'	NULL
r	NULL
``	NULL
;	NULL
'rr'rrf	NULL
0	NULL
10	NULL
20	NULL
30	NULL
10	NULL
20	NULL
80	NULL
0	NULL
10	NULL
20	NULL
30	NULL
0	NULL
10	NULL
20	NULL
30	NULL
10	NULL
20	NULL
30	NULL
RETENTION	NULL
TIME	NULL
IN	NULL
MINUTES	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

HPLC	NULL
analysis	NULL
of	NULL
metabolites	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
produced	NULL
by	NULL
tonsillar	NULL
B	NULL
,	NULL
T	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

HPLC	NULL
analysis	NULL
of	NULL
the	NULL
lipid	NULL
extracts	NULL
of	NULL
both	NULL
cells	NULL
and	NULL
media	NULL
obtained	NULL
by	NULL
incubating	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
with	NULL
10°	NULL
m	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
in	NULL
200	NULL
ml	NULL
of	NULL
media	NULL
.	NULL

Cells	NULL
were	NULL
preactivated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
200	NULL
units/ml	NULL
IL-4	NULL
(	NULL
tonsillar	NULL
T	NULL
cells	NULL
were	NULL
also	NULL
activated	NULL
with	NULL
PHA	NULL
)	NULL
and	NULL
subsequently	NULL
cultured	NULL
with	NULL
5	NULL
x	NULL
10°	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
an	NULL
additional	NULL
48	NULL
bh	NULL
.	NULL

At	NULL
72	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
media	NULL
and	NULL
FCS	NULL
were	NULL
replenished	NULL
,	NULL
and	NULL
107	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
added	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h.	NULL
Chromatographic	NULL
conditions	NULL
:	NULL
Zorbax-SIL	NULL
column	NULL
(	NULL
25	NULL
cm	NULL
x	NULL
4.6	NULL
mm	NULL
)	NULL
,	NULL
eluted	NULL
with	NULL
hexane:2-propanol	NULL
(	NULL
90:10	NULL
)	NULL
,	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2	NULL
ml/min	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
elution	NULL
position	NULL
of	NULL
a	NULL
synthetic	NULL
standard	NULL
of	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

At	NULL
the	NULL
elution	NULL
position	NULL
of	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
a	NULL
minor	NULL
lipid	NULL
contaminant	NULL
peak	NULL
was	NULL
noted	NULL
in	NULL
the	NULL
HPLC	NULL
chromatograms	NULL
of	NULL
both	NULL
B9	NULL
and	NULL
tonsillar	NULL
B	NULL
cells	NULL
.	NULL

This	NULL
lipid	NULL
contaminant	NULL
peak	NULL
did	NULL
not	NULL
exhibit	NULL
the	NULL
typical	NULL
UV	NULL
spectrum	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
chromophore	NULL
and	NULL
was	NULL
present	NULL
in	NULL
all	NULL
HPLC	NULL
chromatograms	NULL
,	NULL
including	NULL
control	NULL
incubation	NULL
studies	NULL
without	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
produced	NULL
in	NULL
U937	NULL
and	NULL
tonsillar	NULL
T	NULL
cells	NULL
was	NULL
identified	NULL
unequivocally	NULL
as	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
through	NULL
masss	NULL
spectrometry	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

the	NULL
molecular	NULL
size	NULL
of	NULL
the	NULL
hybridizing	NULL
species	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
analyzing	NULL
24-hydroxylase	NULL
mRNA	NULL
expression	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
data	NULL
indicate	NULL
that	NULL
expression	NULL
of	NULL
VDR	NULL
mRNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
although	NULL
this	NULL
mRNA	NULL
species	NULL
was	NULL
found	NULL
not	NULL
to	NULL
be	NULL
inducible	NULL
in	NULL
U937	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
only	NULL
IL-4	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
there	NULL
was	NULL
an	NULL
apparent	NULL
enhancement	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
expression	NULL
when	NULL
these	NULL
monocytic	NULL
cells	NULL
were	NULL
co-stimulated	NULL
with	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
cDNA	NULL
probe	NULL
failed	NULL
to	NULL
hybridize	NULL
to	NULL
mRNA	NULL
derived	NULL
from	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
treated	NULL
with	NULL
as	NULL
much	NULL
as	NULL
1	NULL
um	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
,	NULL
nor	NULL
was	NULL
24-hydroxylase	NULL
mRNA	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
constitutively	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
nor	NULL
was	NULL
it	NULL
inducible	NULL
by	NULL
treatment	NULL
with	NULL
only	NULL
IL-4	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
IL-4	NULL
and	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
failed	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
EBV-positive	NULL
B9	NULL
cells	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
indicate	NULL
that	NULL
expression	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
is	NULL
not	NULL
induced	NULL
in	NULL
EBV-immortalized	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
either	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
IL-4	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
two	NULL
reagents	NULL
.	NULL

These	NULL
results	NULL
corroborate	NULL
the	NULL
absence	NULL
of	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
metabolism	NULL
observed	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Prior	NULL
cellular	NULL
activation	NULL
has	NULL
become	NULL
a	NULL
hallmark	NULL
of	NULL
lymphoid	NULL
cell	NULL
bioresponsiveness	NULL
to	NULL
1a,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
12	NULL
,	NULL
14	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Although	NULL
all	NULL
other	NULL
known	NULL
target	NULL
cells	NULL
of	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
constitutively	NULL
express	NULL
VDR	NULL
(	NULL
11	NULL
)	NULL
,	NULL
lymphoid	NULL
cells	NULL
are	NULL
unique	NULL
in	NULL
that	NULL
VDR	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
,	NULL
and	NULL
specific	NULL
activation	NULL
events	NULL
are	NULL
re	NULL
quired	NULL
for	NULL
its	NULL
genomic	NULL
up-regulation	NULL
.	NULL

Characterization	NULL
of	NULL
activation	NULL
events	NULL
mediating	NULL
VDR	NULL
up-regulation	NULL
in	NULL
T	NULL
lymphocytes	NULL
has	NULL
only	NULL
recently	NULL
been	NULL
investigated	NULL
,	NULL
and	NULL
initial	NULL
results	NULL
have	NULL
revealed	NULL
the	NULL
intricacy	NULL
of	NULL
this	NULL
cellular	NULL
checkpoint	NULL
controlling	NULL
bioresponsiveness	NULL
to	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
(	NULL
60	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
this	NULL
time	NULL
little	NULL
is	NULL
known	NULL
regarding	NULL
the	NULL
complexity	NULL
of	NULL
signals	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
expression	NULL
of	NULL
VDR	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Although	NULL
initial	NULL
reports	NULL
indicated	NULL
that	NULL
receptor	NULL
expression	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
heterogeneous	NULL
populations	NULL
of	NULL
lymphoid	NULL
cells	NULL
upon	NULL
activation	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
,	NULL
a	NULL
subsequent	NULL
report	NULL
cited	NULL
that	NULL
VDR	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
numerous	NULL
long	NULL
term	NULL
cultured	NULL
human	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
undertook	NULL
experiments	NULL
to	NULL
determine	NULL
if	NULL
VDR	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
if	NULL
its	NULL
expression	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
bioresponsiveness	NULL
to	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
VDR	NULL
,	NULL
either	NULL
at	NULL
the	NULL
mRNA	NULL
or	NULL
protein	NULL
level	NULL
in	NULL
normal	NULL
resting	NULL
B	NULL
lymphocytes	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
14	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

To	NULL
effect	NULL
cellular	NULL
activation	NULL
and	NULL
putatively	NULL
up-regulate	NULL
VDR	NULL
expression	NULL
,	NULL
we	NULL
utilized	NULL
either	NULL
B	NULL
cell	NULL
immortalization	NULL
with	NULL
EBV	NULL
and/or	NULL
exogenous	NULL
supplemen-tation	NULL
with	NULL
IL-4	NULL
.	NULL

EBV-positive	NULL
B	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
constitutively	NULL
express	NULL
VDR	NULL
mRNA	NULL
and	NULL
protein	NULL
at	NULL
modest	NULL
yet	NULL
detectable	NULL
levels	NULL
,	NULL
supporting	NULL
the	NULL
contention	NULL
(	NULL
14	NULL
,	NULL
17	NULL
)	NULL
that	NULL
vitamin	NULL
D	NULL
receptor	NULL
expression	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
activated	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
our	NULL
use	NULL
of	NULL
IL-4	NULL
as	NULL
an	NULL
activating	NULL
agent	NULL
may	NULL
be	NULL
more	NULL
physiologically	NULL
relevant	NULL
for	NULL
induction	NULL
of	NULL
a	NULL
bioresponse	NULL
to	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
.	NULL

Biological	NULL
activities	NULL
of	NULL
IL-4	NULL
are	NULL
mediated	NULL
by	NULL
specific	NULL
cell	NULL
surface	NULL
receptors	NULL
which	NULL
are	NULL
constitutively	NULL
expressed	NULL
on	NULL
primary	NULL
cells	NULL
and	NULL
established	NULL
cell	NULL
lines	NULL
of	NULL
hematopoietic	NULL
lineage	NULL
,	NULL
including	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
monocytes	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Activation	NULL
with	NULL
IL-4	NULL
mimics	NULL
antigen-mediated	NULL
activation	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
cell	NULL
volume	NULL
(	NULL
62	NULL
)	NULL
and	NULL
expression	NULL
of	NULL
13442	NULL
A	NULL
B	NULL
U937	NULL
cells	NULL
B9	NULL
cells	NULL
(	NULL
EBV*	NULL
)	NULL
IL-4	NULL
=	NULL
+	NULL
=o	NULL
=	NULL
-	NULL
s	NULL
40+	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D3	NULL
=-	NULL
-	NULL
++	NULL
to	NULL
t	NULL
404+	NULL
-+	NULL
T	NULL
J	NULL
103	NULL
ee	NULL
,	NULL
VDR	NULL
--	NULL
-	NULL
s	NULL
»	NULL
#	NULL
#	NULL
CB	NULL
e	NULL
(	NULL
4.6	NULL
kb	NULL
)	NULL
24-0H	NULL
--	NULL
«	NULL
a	NULL
(	NULL
3.2	NULL
kb	NULL
)	NULL
caPDH	NULL
--	NULL
@	NULL
ep	NULL
e	NULL
e	NULL
»	NULL
@	NULL
#	NULL
«	NULL
o	NULL
a	NULL
(	NULL
1.3	NULL
kb	NULL
)	NULL
®	NULL
hnd	NULL
bat	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
6	NULL
7	NULL
B	NULL
9	NULL
10	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
by	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
.	NULL

U937	NULL
cells	NULL
(	NULL
monoblasts	NULL
)	NULL
and	NULL
B9	NULL
cells	NULL
(	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
24	NULL
h.	NULL
10	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
were	NULL
electrophoresed	NULL
and	NULL
then	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
hVDR	NULL
cDNA	NULL
probe	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
human	NULL
24-hydroxylase	NULL
cDNA	NULL
probe	NULL
and	NULL
finally	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
P-labeled	NULL
195-base	NULL
pair	NULL
PCR	NULL
product	NULL
complementary	NULL
to	NULL
sequences	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
U937	NULL
cells	NULL
:	NULL
unstimulated	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
+	NULL
5	NULL
x	NULL
10°	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
+	NULL
5	NULL
x	NULL
10	NULL
%	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Lanes	NULL
5-10	NULL
,	NULL
B9	NULL
cells	NULL
:	NULL
unstimulated	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
+	NULL
5	NULL
x	NULL
10	NULL
%	NULL
m	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
+	NULL
5	NULL
x	NULL
107	NULL
``	NULL
m	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
+	NULL
10	NULL
m	NULL
(	NULL
0H	NULL
)	NULL
28D3	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
;	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
+	NULL
100	NULL
units/ml	NULL
IL-4	NULL
+	NULL
5	NULL
x	NULL
10	NULL
m	NULL
1	NULL
@	NULL
a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

activation	NULL
antigens	NULL
,	NULL
including	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
(	NULL
63	NULL
)	NULL
and	NULL
CD23	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
recent	NULL
observations	NULL
of	NULL
IL-4	NULL
effect	NULL
on	NULL
osteoclast	NULL
development	NULL
(	NULL
64	NULL
,	NULL
65	NULL
)	NULL
,	NULL
and	NULL
the	NULL
capacity	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
to	NULL
directly	NULL
up-regulate	NULL
IL-4	NULL
receptors	NULL
(	NULL
66	NULL
)	NULL
,	NULL
link	NULL
this	NULL
lymphokine	NULL
with	NULL
the	NULL
vitamin	NULL
D	NULL
,	NULL
endocrine	NULL
sys-tem	NULL
.	NULL

Additional	NULL
evidence	NULL
supporting	NULL
the	NULL
induction	NULL
of	NULL
VDR	NULL
in	NULL
B	NULL
cells	NULL
was	NULL
obtained	NULL
by	NULL
the	NULL
immunochemical	NULL
detection	NULL
of	NULL
VDR	NULL
protein	NULL
.	NULL

Immunoprecipitated	NULL
cross-reactive	NULL
proteins	NULL
obtained	NULL
from	NULL
activated	NULL
B	NULL
cell	NULL
extracts	NULL
demonstrated	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
VDR	NULL
protein	NULL
derived	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
cross-reactive	NULL
proteins	NULL
derived	NULL
from	NULL
activated	NULL
B	NULL
cells	NULL
which	NULL
exhibit	NULL
reduced	NULL
electrophoretic	NULL
mobility	NULL
may	NULL
be	NULL
indicative	NULL
of	NULL
occupied	NULL
VDR	NULL
that	NULL
has	NULL
undergone	NULL
phosphorylation	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
binding	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
to	NULL
its	NULL
receptor	NULL
and	NULL
receptor	NULL
phosphorylation	NULL
are	NULL
temporally	NULL
related	NULL
events	NULL
(	NULL
57	NULL
,	NULL
67	NULL
)	NULL
provides	NULL
suggestive	NULL
evidence	NULL
for	NULL
initial	NULL
hormone-receptor	NULL
complex	NULL
formation	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

As	NULL
an	NULL
indicator	NULL
of	NULL
cellular	NULL
action	NULL
induced	NULL
by	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
induction	NULL
of	NULL
hormone	NULL
metabolism	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
vitamin	NULL
D	NULL
,	NULL
metabolites	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
strict	NULL
requirement	NULL
for	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
expression	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
,	NULL
emphasizing	NULL
the	NULL
regulatory	NULL
control	NULL
of	NULL
its	NULL
genomic	NULL
transcription	NULL
as	NULL
an	NULL
excellent	NULL
tool	NULL
for	NULL
analysis	NULL
of	NULL
hormone-mediated	NULL
cellular	NULL
effect	NULL
.	NULL

Our	NULL
observation	NULL
of	NULL
a	NULL
failure	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
in	NULL
either	NULL
activated	NULL
normal	NULL
or	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
was	NULL
corroborated	NULL
by	NULL
analysis	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
metabolism	NULL
,	NULL
in	NULL
that	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
1,24	NULL
(	NULL
R	NULL
)	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
or	NULL
other	NULL
known	NULL
metabolites	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
from	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
particularly	NULL
intriguing	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
putative	NULL
regulatory	NULL
role	NULL
of	NULL
self-induced	NULL
metabolism	NULL
of	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
as	NULL
a	NULL
mechanism	NULL
to	NULL
limit	NULL
Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1	NULL
@	NULL
,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
the	NULL
responsiveness	NULL
of	NULL
target	NULL
tissues	NULL
(	NULL
68	NULL
)	NULL
.	NULL

As	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
metabolism	NULL
of	NULL
the	NULL
hormone	NULL
provides	NULL
a	NULL
negative	NULL
feedback	NULL
on	NULL
cellular	NULL
responsiveness	NULL
to	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
,	NULL
one	NULL
would	NULL
expect	NULL
that	NULL
following	NULL
VDR	NULL
up-regulation	NULL
,	NULL
a	NULL
lack	NULL
of	NULL
metabolic	NULL
activity	NULL
would	NULL
initiate	NULL
an	NULL
enhanced	NULL
bioresponsiveness	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
we	NULL
observed	NULL
in	NULL
B	NULL
cells	NULL
a	NULL
refractory	NULL
response	NULL
to	NULL
both	NULL
1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
metabolism	NULL
and	NULL
1,25-	NULL
(	NULL
0O0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
effect	NULL
on	NULL
cellular	NULL
function	NULL
.	NULL

It	NULL
would	NULL
appear	NULL
that	NULL
in	NULL
B	NULL
cells	NULL
a	NULL
hormone-receptor	NULL
complex	NULL
is	NULL
assembled	NULL
but	NULL
that	NULL
it	NULL
does	NULL
not	NULL
participate	NULL
in	NULL
hormone-mediated	NULL
gene	NULL
regulation	NULL
.	NULL

This	NULL
could	NULL
occur	NULL
through	NULL
the	NULL
action	NULL
of	NULL
negative	NULL
regulatory	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
impede	NULL
the	NULL
VDR-1	NULL
@	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
VDRE	NULL
or	NULL
negating	NULL
the	NULL
action	NULL
of	NULL
the	NULL
complex	NULL
once	NULL
it	NULL
is	NULL
bound	NULL
to	NULL
the	NULL
VDRE	NULL
.	NULL

Recent	NULL
evidence	NULL
has	NULL
suggested	NULL
that	NULL
VDRE	NULL
may	NULL
exist	NULL
as	NULL
at	NULL
least	NULL
three	NULL
functionally	NULL
distinct	NULL
classes	NULL
,	NULL
responsive	NULL
to	NULL
either	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
alone	NULL
via	NULL
VDR/VDR	NULL
homodimer	NULL
formation	NULL
,	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
and	NULL
9-cis-retinoic	NULL
acid	NULL
as	NULL
VDR/retinoid	NULL
X	NULL
receptor	NULL
heterodimers	NULL
,	NULL
or	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
and	NULL
all-trans-retinoic	NULL
acid	NULL
as	NULL
VDR/retinoic	NULL
acid	NULL
receptor	NULL
heterodimers	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
a	NULL
given	NULL
responsive	NULL
gene	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
up	NULL
to	NULL
six	NULL
separate	NULL
hormone	NULL
response	NULL
pathways	NULL
that	NULL
are	NULL
governed	NULL
by	NULL
the	NULL
ligands	NULL
1,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
all-trans-RA	NULL
and	NULL
9-cis-RA	NULL
acting	NULL
individually	NULL
,	NULL
or	NULL
by	NULL
the	NULL
three	NULL
binary	NULL
combinations	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
a	NULL
single	NULL
ligand	NULL
,	NULL
the	NULL
responsive	NULL
target	NULL
gene	NULL
may	NULL
be	NULL
activated	NULL
only	NULL
moderately	NULL
,	NULL
whereas	NULL
addition	NULL
of	NULL
a	NULL
second	NULL
or	NULL
third	NULL
ligand	NULL
would	NULL
correspondingly	NULL
induce	NULL
a	NULL
greater	NULL
maximal	NULL
response	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Whatever	NULL
the	NULL
case	NULL
,	NULL
our	NULL
studies	NULL
clearly	NULL
demonstrate	NULL
that	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
treatment	NULL
with	NULL
1	NULL
@	NULL
«	NULL
,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
up-regulate	NULL
expression	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
B	NULL
lymphocytes	NULL
(	NULL
either	NULL
normal	NULL
or	NULL
EBV-immortalized	NULL
)	NULL
were	NULL
incapable	NULL
of	NULL
up-regulating	NULL
the	NULL
24-hydroxylase	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
was	NULL
sufficient	NULL
to	NULL
inhibit	NULL
expression	NULL
of	NULL
the	NULL
CD23b	NULL
gene	NULL
;	NULL
this	NULL
effect	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Experiments	NULL
are	NULL
currently	NULL
underway	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
functional	NULL
block	NULL
in	NULL
B	NULL
lymphocytes	NULL
can	NULL
be	NULL
ascribed	NULL
to	NULL
aberrant	NULL
complex	NULL
assembly	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
a	NULL
functional	NULL
block	NULL
for	NULL
1a,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
gene	NULL
regulation	NULL
in	NULL
normal	NULL
and	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
the	NULL
components	NULL
and	NULL
events	NULL
critical	NULL
for	NULL
1	NULL
«	NULL
,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
gene	NULL
regulation	NULL
can	NULL
be	NULL
identified	NULL
and	NULL
molecularly	NULL
characterized	NULL
by	NULL
direct	NULL
comparison	NULL
between	NULL
B	NULL
cells	NULL
and	NULL
hormone-responsive	NULL
T	NULL
cells	NULL
and	NULL
mono	NULL
cytes	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Deborah	NULL
Morgan	NULL
for	NULL
performing	NULL
the	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
.	NULL

Thanks	NULL
are	NULL
due	NULL
to	NULL
the	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Section	NULL
of	NULL
Experimental	NULL
Pathology	NULL
at	NULL
the	NULL
Roger	NULL
Williams	NULL
Medical	NULL
Center	NULL
for	NULL
their	NULL
helpful	NULL
discussion	NULL
.	NULL

REFERENCES	NULL
.	NULL

Amento	NULL
,	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
Steroids	NULL
49	NULL
,	NULL
55-72	NULL
.	NULL

Rigby	NULL
,	NULL
W.	NULL
F.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
9	NULL
,	NULL
54-58	NULL
.	NULL

Manolagas	NULL
,	NULL
S.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Yu	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Kidney	NULL
Int	NULL
.	NULL

38	NULL
,	NULL
S9-S16	NULL
.	NULL

Pols	NULL
,	NULL
H.	NULL
A.	NULL
P.	NULL
,	NULL
Birkenhager	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Foekens	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
vanLeeuwen	NULL
,	NULL
J.	NULL
P.	NULL
T.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

37	NULL
,	NULL
873-876	NULL
.	NULL

Rigby	NULL
,	NULL
W.	NULL
F.	NULL
C.	NULL
,	NULL
Denome	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Fanger	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

74	NULL
,	NULL
1451-1455	NULL
6	NULL
.	NULL

Lemire	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Adams	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Kermani-Arab	NULL
,	NULL
V.	NULL
,	NULL
Bakke	NULL
,	NULL
A.	NULL
,	NULL
Sakai	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Jordan	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

34	NULL
,	NULL
3032-3035	NULL
7	NULL
.	NULL

Abe	NULL
,	NULL
E.	NULL
,	NULL
Miyaura	NULL
,	NULL
C.	NULL
,	NULL
Hiroshi	NULL
,	NULL
S.	NULL
,	NULL
Takeda	NULL
,	NULL
M.	NULL
,	NULL
Konno	NULL
,	NULL
K.	NULL
,	NULL
Yamashi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Suda	NULL
,	NULL
T.	NULL
(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

78	NULL
,	NULL
4990-4994	NULL
8	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Bone	NULL
(	NULL
Elmsford	NULL
)	NULL
7	NULL
,	NULL
23-28	NULL
9	NULL
.	NULL

Nemere	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

80	NULL
,	NULL
C165-C169	NULL
10	NULL
.	NULL

Norman	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Bouillon	NULL
,	NULL
R.	NULL
,	NULL
Farach-Carson	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Bishop	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Nemere	NULL
,	NULL
I.	NULL
,	NULL
Zhao	NULL
,	NULL
J.	NULL
,	NULL
Muralidharan	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
and	NULL
Okamura	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
20022-20030	NULL
11	NULL
.	NULL

Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Nutr	NULL
.	NULL

11	NULL
,	NULL
189-216	NULL
12	NULL
.	NULL

Bhalla	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Amento	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Holick	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Krane	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

57	NULL
,	NULL
1308-1310	NULL
13	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Bone	NULL
(	NULL
Elmsford	NULL
)	NULL
7	NULL
,	NULL
23-28	NULL
14	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
wa	NULL
G0	NULL
bo	NULL
i	NULL
of	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

Response	NULL
of	NULL
Human	NULL
B	NULL
Lymphocytes	NULL
to	NULL
1a,25-Dihydroxyvitamin	NULL
D	NULL
,	NULL
Science	NULL
221	NULL
,	NULL
1181-1183	NULL
Rigby	NULL
,	NULL
W.	NULL
F.	NULL
C.	NULL
,	NULL
Denome	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Fanger	NULL
,	NULL
M.	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79	NULL
,	NULL
1659-1664	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3747-3752	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

186	NULL
,	NULL
2734-2740	NULL
Kizaki	NULL
,	NULL
M.	NULL
,	NULL
Norman	NULL
,	NULL
A.	NULL
,	NULL
Bishop	NULL
,	NULL
J.	NULL
,	NULL
Lin	NULL
,	NULL
C.	NULL
,	NULL
Karmakar	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1238-1247	NULL
Tho	NULL
,	NULL
S.	NULL
,	NULL
Takahashi	NULL
,	NULL
T.	NULL
,	NULL
Kura	NULL
,	NULL
F.	NULL
,	NULL
Sugiyama	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Hoshino	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

186	NULL
,	NULL
4427-4431	NULL
Chen	NULL
,	NULL
W.-C.	NULL
,	NULL
Vayuvegula	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Gupta	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

69	NULL
,	NULL
639-646	NULL
Shiosawa	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Fujita	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Immunopharmacol	NULL
.	NULL

9	NULL
,	NULL
719-723	NULL
Muller	NULL
,	NULL
K.	NULL
,	NULL
Heilmann	NULL
,	NULL
C.	NULL
,	NULL
Poulsen	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Barington	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Bendtzen	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Immunopharmacology	NULL
21	NULL
,	NULL
121-128	NULL
DeFrance	NULL
,	NULL
T.	NULL
,	NULL
Aubry	NULL
,	NULL
J.	NULL
,	NULL
Rousset	NULL
,	NULL
F.	NULL
,	NULL
VanBervliet	NULL
,	NULL
B.	NULL
,	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Takebe	NULL
,	NULL
Y.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
DeVries	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
1459-1467	NULL
Vercelli	NULL
,	NULL
D.	NULL
,	NULL
Jabara	NULL
,	NULL
H.	NULL
,	NULL
Lee	NULL
,	NULL
B.	NULL
,	NULL
Woodland	NULL
,	NULL
N.	NULL
,	NULL
Geba	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Leung	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1406-1416	NULL
Thorley-Lawson	NULL
,	NULL
D.	NULL
,	NULL
Nadler	NULL
,	NULL
L.	NULL
,	NULL
Bhan	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schooley	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

134	NULL
,	NULL
3007-3012	NULL
Sugden	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Metzenberg	NULL
,	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

46	NULL
,	NULL
800-807	NULL
Mayumi	NULL
,	NULL
M.	NULL
,	NULL
Kawabe	NULL
,	NULL
T.	NULL
,	NULL
Kim	NULL
,	NULL
K.	NULL
,	NULL
Heike	NULL
,	NULL
T.	NULL
,	NULL
Katamura	NULL
,	NULL
K.	NULL
,	NULL
Yodoi	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Mikawa	NULL
,	NULL
H.	NULL
(	NULL
1988	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

71	NULL
,	NULL
202-206	NULL
Kikutani	NULL
,	NULL
H.	NULL
,	NULL
Inui	NULL
,	NULL
S.	NULL
,	NULL
Sato	NULL
,	NULL
R.	NULL
,	NULL
Barsumian	NULL
,	NULL
E.	NULL
,	NULL
Owaki	NULL
,	NULL
H.	NULL
,	NULL
Yamasaki	NULL
,	NULL
K.	NULL
,	NULL
Kaisho	NULL
,	NULL
T.	NULL
,	NULL
Uchibayashi	NULL
,	NULL
N.	NULL
,	NULL
Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Tsunasawa	NULL
,	NULL
S.	NULL
,	NULL
Sakiyama	NULL
,	NULL
F.	NULL
,	NULL
Suemura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
657-665	NULL
Aubry	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Pochon	NULL
,	NULL
S.	NULL
,	NULL
Graber	NULL
,	NULL
P.	NULL
,	NULL
Jansen	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
358	NULL
,	NULL
505-507	NULL
Flores-Romo	NULL
,	NULL
L.	NULL
,	NULL
Shields	NULL
,	NULL
J.	NULL
,	NULL
Humbert	NULL
,	NULL
Y.	NULL
,	NULL
Graber	NULL
,	NULL
P.	NULL
,	NULL
Aubry	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Gauchat	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Ayala	NULL
,	NULL
G.	NULL
,	NULL
Allet	NULL
,	NULL
B.	NULL
,	NULL
Chavez	NULL
,	NULL
M.	NULL
,	NULL
Bazin	NULL
,	NULL
H.	NULL
,	NULL
Capron	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bonnefoy	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1038-1041	NULL
Peacock	NULL
,	NULL
M.	NULL
,	NULL
Johes	NULL
,	NULL
S.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Amenito	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Kunick	NULL
,	NULL
J.	NULL
,	NULL
Koune	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Holick	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1982	NULL
)	NULL
in	NULL
Vitamin	NULL
D	NULL
:	NULL
Chemical	NULL
,	NULL
Biochemical	NULL
and	NULL
Clinical	NULL
Endocrinology	NULL
of	NULL
Calcium	NULL
Metabolism	NULL
(	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Schaefer	NULL
,	NULL
K.	NULL
,	NULL
Grigoleit	NULL
,	NULL
H.-G.	NULL
,	NULL
and	NULL
von	NULL
Herrath	NULL
,	NULL
D.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

83-85	NULL
,	NULL
Walter	NULL
de	NULL
Gruyter	NULL
&	NULL
Co.	NULL
,	NULL
Berlin	NULL
Hewison	NULL
,	NULL
M.	NULL
,	NULL
Barker	NULL
,	NULL
S.	NULL
,	NULL
Brennan	NULL
,	NULL
A.	NULL
,	NULL
Nathan	NULL
,	NULL
J.	NULL
,	NULL
Katz	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
O'Riordan	NULL
,	NULL
J.	NULL
L.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Immunology	NULL
68	NULL
,	NULL
247-252	NULL
Nunn	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Katz	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Barker	NULL
,	NULL
S.	NULL
,	NULL
Fraher	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Hewison	NULL
,	NULL
M.	NULL
,	NULL
Hendy	NULL
,	NULL
G.	NULL
N.	NULL
,	NULL
and	NULL
O'Riordan	NULL
,	NULL
J.	NULL
L.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Immunology	NULL
59	NULL
,	NULL
479-484	NULL
Morgan	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Roome	NULL
,	NULL
A.	NULL
,	NULL
Maizel	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Sharma	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
3190-3194	NULL
Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Nillson	NULL
,	NULL
K.	NULL
(	NULL
1976	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
17	NULL
,	NULL
565-577	NULL
Maizel	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Mehta	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Kouttab	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Bator	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Sahasrabuddhe	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

80	NULL
,	NULL
5047-5051	NULL
Hahn	NULL
,	NULL
C.	NULL
N.	NULL
,	NULL
Baker	NULL
,	NULL
E.	NULL
,	NULL
Laslo	NULL
,	NULL
P.	NULL
,	NULL
May	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Omdahl	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Sutherland	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Cytogenet	NULL
.	NULL

Cell	NULL
Genet	NULL
.	NULL

62	NULL
,	NULL
192-193	NULL
Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Friedman	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Joe	NULL
,	NULL
S.	NULL
,	NULL
Baca	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Turpin	NULL
,	NULL
J.	NULL
,	NULL
Dveksler	NULL
,	NULL
G.	NULL
,	NULL
Meltzer	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
Dieffenbach	NULL
,	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
1433-1442	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
in	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

13443	NULL
Marzluff	NULL
,	NULL
W.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

181	NULL
,	NULL
30-36	NULL
Shapiro	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Wahli	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
and	NULL
Keller	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
DNA	NULL
(	NULL
N.	NULL
¥	NULL
)	NULL
7	NULL
,	NULL
47-55	NULL
Schneider	NULL
,	NULL
C.	NULL
,	NULL
Newman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Sutherland	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Asser	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Greaves	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

257	NULL
,	NULL
10766-10769	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
Reddy	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
and	NULL
Tserng	NULL
,	NULL
K.	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochemistry	NULL
28	NULL
,	NULL
1763-1769	NULL
Clark	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Reddy	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Santos-Moore	NULL
,	NULL
A.	NULL
,	NULL
Wankadiya	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
Reddy	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Eil	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Lasky	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Bioorg	NULL
.	NULL

&	NULL
Med	NULL
.	NULL

Chem	NULL
.	NULL

Lett	NULL
.	NULL

8	NULL
,	NULL
1873-1878	NULL
Bligh	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
Dyer	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1959	NULL
)	NULL
Can	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

Physiol	NULL
.	NULL

37	NULL
,	NULL
911-917	NULL
Jones	NULL
,	NULL
G.	NULL
,	NULL
Kano	NULL
,	NULL
K.	NULL
,	NULL
Yamada	NULL
,	NULL
S.	NULL
,	NULL
Furusawa	NULL
,	NULL
T.	NULL
,	NULL
Takayama	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Suda	NULL
,	NULL
T.	NULL
(	NULL
1984	NULL
)	NULL
Biochemistry	NULL
28	NULL
,	NULL
3749-3754	NULL
Miyaura	NULL
,	NULL
C.	NULL
,	NULL
Abe	NULL
,	NULL
E.	NULL
,	NULL
Kuribayaski	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
H.	NULL
,	NULL
Konno	NULL
,	NULL
K.	NULL
,	NULL
Nishii	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Suda	NULL
,	NULL
T.	NULL
(	NULL
1981	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

102	NULL
,	NULL
937-943	NULL
Mezzetti	NULL
,	NULL
G.	NULL
,	NULL
Bagnara	NULL
,	NULL
G.	NULL
,	NULL
Monti	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Bonsi	NULL
,	NULL
L.	NULL
,	NULL
Brunelli	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Bar-biroli	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Life	NULL
Sci	NULL
.	NULL

34	NULL
,	NULL
2185-2191	NULL
Fargeas	NULL
,	NULL
C.	NULL
,	NULL
Wu	NULL
,	NULL
C.	NULL
,	NULL
Luo	NULL
,	NULL
H.	NULL
,	NULL
Sarfati	NULL
,	NULL
M.	NULL
,	NULL
Delespesse	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
4053-4058	NULL
Arnaout	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
1037-1050	NULL
Rosmarin	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Weil	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Rosner	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Arnaout	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
131-136	NULL
Yokota	NULL
,	NULL
A.	NULL
,	NULL
Kikutani	NULL
,	NULL
H.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Sato	NULL
,	NULL
R.	NULL
,	NULL
Barsumian	NULL
,	NULL
E.	NULL
,	NULL
Suemura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
611-618	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
in	NULL
Vitamin	NULL
D	NULL
:	NULL
Chemical	NULL
,	NULL
Biochemical	NULL
and	NULL
Clinical	NULL
Update	NULL
(	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Schaefer	NULL
,	NULL
K.	NULL
,	NULL
Grigoleit	NULL
,	NULL
H.-G.	NULL
,	NULL
and	NULL
von	NULL
Herrath	NULL
,	NULL
D.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

97-106	NULL
,	NULL
Walter	NULL
de	NULL
Gruyter	NULL
&	NULL
Co.	NULL
,	NULL
Berlin	NULL
Mangelsdort	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
354-358	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259	NULL
,	NULL
1167-1173	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Sleator	NULL
,	NULL
N.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

131	NULL
,	NULL
378-385	NULL
Chen	NULL
,	NULL
K.	NULL
,	NULL
Prahl	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
DeLuca	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
45483-4547	NULL
Reichel	NULL
,	NULL
H.	NULL
,	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
and	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

820	NULL
,	NULL
980-991	NULL
Yu	NULL
,	NULL
X.	NULL
,	NULL
Mocharla	NULL
,	NULL
H.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7588-7595	NULL
Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
825	NULL
,	NULL
537-540	NULL
Rabin	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
2035-2939	NULL
Noelle	NULL
,	NULL
R.	NULL
,	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Ohara	NULL
,	NULL
J.	NULL
,	NULL
Ubr	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Vitetta	NULL
,	NULL
E.	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

81	NULL
,	NULL
6149-6154	NULL
Ueno	NULL
,	NULL
K.	NULL
,	NULL
Katayama	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Koshihara	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

189	NULL
,	NULL
1521-1526	NULL
Kasono	NULL
,	NULL
K.	NULL
,	NULL
Sato	NULL
,	NULL
K.	NULL
,	NULL
Sato	NULL
,	NULL
Y.	NULL
,	NULL
Tsushima	NULL
,	NULL
T.	NULL
,	NULL
Shizume	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Demura	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

21	NULL
,	NULL
179-188	NULL
Lacey	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Erdmann	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Tan	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
and	NULL
O'hara	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

53	NULL
,	NULL
122-134	NULL
Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
DeLuca	NULL
,	NULL
H.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
10025-10029	NULL
Reinhardt	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Horst	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
15917-15921	NULL
Carlberg	NULL
,	NULL
C.	NULL
,	NULL
Bendik	NULL
,	NULL
I.	NULL
,	NULL
Wyss	NULL
,	NULL
A.	NULL
,	NULL
Meier	NULL
,	NULL
E.	NULL
,	NULL
Sturzenbecker	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Grippo	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Hunziker	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
861	NULL
,	NULL
657-660	NULL
Schrider	NULL
,	NULL
M.	NULL
,	NULL
Bendik	NULL
,	NULL
I.	NULL
,	NULL
Becker-André	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Carlberg	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17830-17836	NULL

